Mr David Hrouda

Professional statement

Mr David Hrouda qualified at St. Thomas’s Hospital Medical School in 1989 and carried out postgraduate surgical training in London at St George’s Hospital, the Institute of Urology (University College Hospital) and Charing Cross Hospital. He was awarded an MD thesis (2000) for research into prostate cancer vaccines and gene therapy. He then undertook further training in laparoscopic urological surgery at Princess Alexandra Hospital in Brisbane and subsequently learned additional techniques while doing a preceptorship at The Cleveland Clinic, Cleveland, Ohio. He has been a consultant urological surgeon at Imperial College Healthcare NHS Trust (Charing Cross Hospital) and West Middlesex University Hospital since 2002. He has a special interest in the diagnosis and treatment of testis, kidney and bladder cancer with specialist skills in laparoscopic surgery, cystectomy and bladder reconstruction. He has performed over 1000 laparoscopic kidney operations. He performs post-chemotherapy retroperitoneal lymph node dissection for the North West London and Mount Vernon cancer networks. He is President of the Urostomy Association (South West London). In 2012-2014 he was a member of the National Cancer Research Institute (NCRI) clinical studies group for bladder cancer and a member of the screening, prevention & early diagnosis advisory group (SPED) of the NCRI. He was a member of the senate of the clinical reference group for specialist urology, NHS England and is currently a member of the Cancer Commissioning Board Clinical Advisory Group (London). He is the Clinical Director for Specialist Surgery at Imperial College Healthcare NHS Trust and joint chair of the urology pathway group of the Royal Marsden cancer vanguard.